Concord Biotech makes a decent debut on the bourse’s ; Shares close 27% premium over the issue price at Listing
MUMBAI, AUGUST 18, 2023 (GPN): Ahmedabad-based Concord Biotech Limited a biotechnology company and one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based…









